Anthropic makes IPO prospectus public and reports $16.3bn in half-year revenue
The prospectus shows a $80.7bn net loss in the first half of 2026. The ticker on the Nasdaq is to be ANT.
On 26 October 2026 Anthropic publicly filed its IPO prospectus (Form S-1) with the US securities regulator. The lab wants to be listed on the Nasdaq under the ticker ANT.
According to the prospectus, revenue in the first half of 2026 was $16.3bn. In the whole of 2025 it was $4.6bn. The second quarter brought in $11.6bn, after $4.7bn in the first. The net loss for the half-year was $80.7bn. In the second quarter Anthropic made an operating profit of $974m.
The prospectus does not name an offering price or date. Goldman Sachs and Morgan Stanley are leading the offering. As of 30 September Anthropic employed about 5,300 people.
Sources: Form S-1 at the SEC, summary at Yahoo Finance, as of 26 October 2026. More figures under Labs & money.